At the Core

Glengary combines an unparalleled network of support services with investment capital. Our initial investment in an early stage company is typically made after its product or service has been validated in the market. We then work with its leadership to achieve mutually-defined milestones before participating in follow-on rounds of financing, frequently at a size that is a multiple of our initial investment.

More than Money

Believing that early stage companies need "more than money" to be successful, Glengary stands ready to assist all facets of a Client Company's operations, ensuring that stage-critical investment capital, focus, proper skill sets and other resources are brought to the table, while establishing intelligent and dynamic strategic alliances with individuals and organizations virtually impossible for entrepreneurs to access on their own.

Investment

Glengary’s initial investment in a Client Company is typically made after its product or service has been validated in the market. We then work with its leadership to achieve mutually-defined milestones before participating in follow-on rounds of financing, frequently at a size that is a multiple of our initial investment. We bridge the funding gap between angel investors and institutional venture funds. 

Management

Glengary’s involvement with early-stage companies is proven to enhance credibility, reduce distractions to management and create momentum, as well as increase valuations and opportunities for success in subsequent fundraising rounds.

Services

Glengary works with entrepreneurs to develop business and financial plans focused on achieving milestones critical to raising additional funding. Our experiences supporting early stage companies allow us to be highly constructive in the Client Company’s evolution

Award winning Portfolio Company's

Many of Glengary's portfolio company's have been recognized and are the recipients of industry awards. An example would be:

  • October 22, 2012- Neuros Medical awarded the Gold Electrode Award.
  • October 3, 2012- EndoSphere was selected as a Fierce 15 award winner.
  • June 2012- Cleveland HeartLab was named OVA venture of the year.
  • April 2012- SparkBase received Technology Company of the year award.
  • February 9, 2012- OnShift received the LTC Link Elite Supplier award.
  •  
  •  
view all partners

Partner Profiles

Robert L. Meyer
Operating Partner
view all news

Recent Press

Neuros Medical Enrolls First Patent in Pivotal Study

Cleveland, OH, January 28, 2015– Neuros Medical, Inc., a medical device company, announced it has enrolled the first patients in its pivotal clinical trial to evaluate the Company’s patented Altius® System High Frequency Nerve Block technology for the management of intractable limb pain of amputees. When completed, the results will support a PreMarket Approval Application to FDA in order to market the device.

read more